Cardlytics (CDLX) EBITDA margin US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
EBITDA margin, % ? -33.0% -140.8% -32.0% -54.8% -8.46%   -33.2%  
Changes by years, y/y, % -11pp -108pp +109pp -23pp +46pp     -17.3%

Cardlytics. EBITDA margin, %

Cardlytics. EBITDA margin, changes, pp

Cardlytics (CDLX) EBITDA margin US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
EBITDA margin, % ? -6.43% 0.00% -121.6% 2.32% -18.2%   -33.2%
Changes by years, y/y, % +17pp -8pp +80pp +11pp -12pp    
Changes by quarters, q/q, % +3pp +6pp -122pp +124pp -21pp    

Cardlytics. EBITDA margin, %

Cardlytics. EBITDA margin, changes, pp

Cardlytics. EBITDA margin, changes, pp